- Home
- SANG vs NKTX Comparison
SANG vs NKTX Comparison
Compare SANG & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANG
- NKTX
- Stock Information
- Founded
- SANG 1984
- NKTX 2015
- Country
- SANG Canada
- NKTX United States
- Employees
- SANG N/A
- NKTX N/A
- Industry
- SANG Computer Software: Programming Data Processing
- NKTX Biotechnology: Pharmaceutical Preparations
- Sector
- SANG Technology
- NKTX Health Care
- Exchange
- SANG Nasdaq
- NKTX Nasdaq
- Market Cap
- SANG 193.2M
- NKTX 225.1M
- IPO Year
- SANG 2021
- NKTX 2020
- Fundamental
- Price
- SANG $6.68
- NKTX $2.34
- Analyst Decision
- SANG
- NKTX Strong Buy
- Analyst Count
- SANG 0
- NKTX 5
- Target Price
- SANG N/A
- NKTX $15.20
- AVG Volume (30 Days)
- SANG 7.8K
- NKTX 2.2M
- Earning Date
- SANG 02-06-2025
- NKTX 11-07-2024
- Dividend Yield
- SANG N/A
- NKTX N/A
- EPS Growth
- SANG N/A
- NKTX N/A
- EPS
- SANG N/A
- NKTX N/A
- Revenue
- SANG $244,406,000.00
- NKTX N/A
- Revenue This Year
- SANG $3.36
- NKTX N/A
- Revenue Next Year
- SANG $7.39
- NKTX N/A
- P/E Ratio
- SANG N/A
- NKTX N/A
- Revenue Growth
- SANG N/A
- NKTX N/A
- 52 Week Low
- SANG $2.50
- NKTX $2.22
- 52 Week High
- SANG $6.93
- NKTX $16.24
- Technical
- Relative Strength Index (RSI)
- SANG 56.18
- NKTX 36.78
- Support Level
- SANG $6.45
- NKTX $2.22
- Resistance Level
- SANG $6.93
- NKTX $2.50
- Average True Range (ATR)
- SANG 0.22
- NKTX 0.23
- MACD
- SANG 0.03
- NKTX 0.01
- Stochastic Oscillator
- SANG 72.22
- NKTX 12.74
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.
About NKTX Nkarta Inc.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.